Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408

Background: As docetaxel plus S-1 may be feasible for cancer treatment, we conducted a phase I/II trial to determine the recommended docetaxel dose and the fixed S-1 dose (phase I), as well as confirm the regimen’s efficacy and safety (phase II) for previously-treated patients with advanced non-smal...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Clin Med
मुख्य लेखकों: Takayama, Koichi, Uchino, Junji, Fujita, Masaki, Tokunaga, Shoji, Imanaga, Tomotoshi, Morinaga, Ryotaro, Ebi, Noriyuki, Saeki, Sho, Matsukizono, Kazuya, Wataya, Hiroshi, Yamada, Tadaaki, Nakanishi, Yoichi
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6947543/
https://ncbi.nlm.nih.gov/pubmed/31842381
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8122196
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन